Navigation Links
Catalyst Pharmaceutical Partners Selected to Present at Epilepsy Conference Highlighting New and Promising Therapies
Date:2/17/2010

logical side effects profile," said Steven Miller, Ph.D., Catalyst's Chief Scientific Officer.  "CPP-115 was designed specifically to enhance the deactivation of GABA aminotransferase compared to Sabril®.  This enhanced action is expected to lead to significantly higher potency and may lead to reduced, or eliminated, visual field defects.  Sabril's® visual field defects are its most serious side effect and the main reason that the drug is sold only through a very restrictive Risk Evaluation and Mitigation Strategy (REMS) program.  We are hopeful that CPP-115 will prove to be an effective anti-epileptic with a more favorable safety and efficacy profile than Sabril®."

The conference features leading innovators, clinical investigators and industry leaders who provide insight into the discovery and development of pioneering drugs, biologics and devices for epilepsy with the goal of accelerating patient access to new treatments. The selected presenters are scheduled to discuss the most innovative therapies in development for epilepsy.  For additional program information, please visit www.epilepsy.com/node/985708.  

About CPP-115

CPP-115 is Catalyst's lead compound for the treatment of epilepsy and addiction being developed as part of an exclusive worldwide license between Northwestern University and Catalyst. CPP-115 is covered by two composition of matter patents related to a new class of GABA aminotransferase inhibitors. CPP-115 allows Catalyst to potentially explore a broad range of CNS applications, starting with epilepsy, which could benefit from the inhibition of GABA aminotransferase.


'/>"/>
SOURCE Catalyst Pharmaceutical Partners, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. IDEXX Laboratories Announces Catalyst Dx(R) Placement Total for 2009 and Installed Base of SmartService(TM) Customers
2. Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results
3. Catalyst Pharmaceutical Partners, Inc. Announces Organizational Changes and Extension of Chief Executives Employment Agreement
4. Catalyst Pharmaceutical Partners, Inc. Announces the Closing of $3.97 Million Registered Direct Offering
5. Sigma-Aldrich(R) Partners With Flow Chemistry Leader ThalesNano to Provide CatCart(R) Catalyst Products for Rapidly Growing Market
6. Catalyst Pharmaceutical Partners, Inc. To Raise $3.97 Million In Registered Direct Offering
7. Catalyst Pharmaceutical Partners Continues Clinical Development of CPP-109 For The Treatment of Cocaine and Methamphetamine Addiction
8. Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction
9. Catalyst Reaches Enrollment Target for its U.S. Phase II Cocaine Trial
10. Catalyst Pharmaceutical Partners Announces Publication of Animal Data Demonstrating Vigabatrin Effective for Weight Loss
11. Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 2014   Taiho Oncology, Inc. , a ... Japan ), announced that the U.S. Food ... for TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), ... the treatment of refractory metastatic colorectal cancer (mCRC), ... NDA submission to the FDA. According to the ...
(Date:10/20/2014)... YORK and RALEIGH, N.C., Oct. 20, 2014 ... Hereditary Neuropathy Foundation (HNF), both philanthropies, announced today ... drug candidates for the treatment of the rare ... BioPontis Alliance announced its alliance model earlier ... a first demonstration of a collaborative model where ...
(Date:10/18/2014)... , Oct. 18, 2014  In a ... Rights Campaign (HRC), the nation,s largest lesbian, gay, ... endorsed the use of Truvada for Pre-Exposure Prophylaxis ... tool used to prevent the spread of a ... the only brand name anti-HIV drug combination currently ...
Breaking Medicine Technology:Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 2Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 3Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 4The Hereditary Neuropathy Foundation and BioPontis Alliance for Rare Disease Partner to Develop Treatments for Charcot-Marie-Tooth 2The Hereditary Neuropathy Foundation and BioPontis Alliance for Rare Disease Partner to Develop Treatments for Charcot-Marie-Tooth 3HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 2HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 3
(Date:10/20/2014)... 20, 2014 JZ Fitness, an independently ... corporate wellness programming, authorship, international lecturing and community wellness, ... announce the release of the JZ Fitness nutrition app, ... of coaching thousands of individuals on nutrition, Jenn Zerling ... does not require calorie counting or cumbersome food logging. ...
(Date:10/20/2014)... 20, 2014 Rockynol Retirement Community ... on Oct. 14. The $11 million project will include ... a cooked-to-order kitchen with full-service restaurant style dining. , ... for first class Assisted Living apartments,” said Kara Hanzie, ... the highest quality of care and this investment is ...
(Date:10/20/2014)... Unveiled at the Sept. 18 board meeting, ... estimates member hospital ROI on membership dues at 12.5. In ... provides $12.50 in value to member hospitals. The calculation used ... Dues)/Member Dues. , “This is the first time we’ve ... think the methodology is really sound,” said Bill Ryan ...
(Date:10/19/2014)... Hastings and Hastings, a Phoenix personal ... throughout the greater Phoenix area and across Arizona reports ... to catastrophic automobile accidents. Statistics have indicated a steady ... Arizona. As such, Hastings and Hastings has seen a ... those who have been injured through no fault of ...
(Date:10/19/2014)... working in the garment industry for decades, LunaDress’ dress specialists ... one of the company’s top designers, many ladies like prom ... add beauty to them. Chiffon floor length outfits are also ... selection of 2014 long prom dresses. , As a ... in over 20 popular designs. The company intends to meet ...
Breaking Medicine News(10 mins):Health News:JZ Fitness Nutrition App Launches on iTunes 2Health News:JZ Fitness Nutrition App Launches on iTunes 3Health News:Rockynol Retirement Community Expands Assisted Living Center 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 2Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 3Health News:2014 Long Prom Dresses From LunaDress Now Available In Over 20 Popular Designs 2
... Speaking more than one language may boost brain function, experts ... people who speak only one language in certain mental abilities, ... on important information. This means bilingual people are better at ... a time, said Judith Kroll, director of the Center ...
... , FRIDAY, Feb. 18 (HealthDay News) -- The ... varies greatly, researchers say, with some providing useful medical ... thinly veiled advertising sites. Only half of the ... that was in line with current diabetes science and ...
... Tempe, Ariz.-Arizona State University (ASU) and Taiwan,s Chang ... establish an international Biosignatures Center aimed at the ... and other diseases. ASU,s Nobel Laureate, Leland ... Institute,s Center for Sustainable Health (CSH) and will ...
... lung cancer screening researchers, doctors and advocates. The ... Lung Cancer Action Program (I-ELCAP) Screening Conferences. , ... Early Lung Cancer Action Program (I-ELCAP) and the ... Lung Cancer Consortium (ILCCO). This meeting between ...
... Colo. (Feb. 18, 2011) -- When the body is deprived ... or lungs can be injured as a result. The problem ... Yet some athletes deliberately train at high altitude, with less ... the reduced oxygen. Now a doctor at the University ...
... Unlike alcohol abuse problems and antisocial behavior, depression doesn,t ... and 40s it continues to increase, a new ... found. The longitudinal analysis examined the influences of ... their alcohol abuse, antisocial behavior and depression over a ...
Cached Medicine News:Health News:Diabetes Social Networking Web Sites Vary in Quality 2Health News:Diabetes Social Networking Web Sites Vary in Quality 3Health News:Innovative International Healthcare Partnership established at Arizona State University 2Health News:World's largest lung cancer screening conference to address benefits of CT scans 2Health News:Study links hypoxia and inflammation in many diseases 2Health News:Depression symptoms increase over time for addiction-prone women 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: